CONMED Corporation
CNMD
$58.29
-$0.6278-1.07%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 132.42M | 131.74M | 98.59M | 82.35M | 64.46M |
Total Depreciation and Amortization | 70.46M | 70.15M | 70.05M | 70.28M | 70.17M |
Total Amortization of Deferred Charges | 7.10M | 7.46M | 7.56M | 7.66M | 7.76M |
Total Other Non-Cash Items | -3.29M | -19.16M | 8.30M | 15.07M | 22.54M |
Change in Net Operating Assets | -39.72M | -10.16M | -9.55M | -17.04M | -39.58M |
Cash from Operations | 166.97M | 180.03M | 174.95M | 158.32M | 125.35M |
Capital Expenditure | -13.08M | -13.90M | -15.87M | -16.81M | -19.03M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | 0.00 | 0.00 | -1.00M | -1.00M |
Cash from Investing | -13.08M | -13.90M | -15.87M | -17.81M | -20.03M |
Total Debt Issued | 751.00M | 781.00M | 819.00M | 773.00M | 692.00M |
Total Debt Repaid | -823.00M | -857.00M | -901.00M | -854.00M | -780.00M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -24.65M | -24.62M | -24.61M | -24.56M | -24.50M |
Other Financing Activities | -54.35M | -58.07M | -50.49M | -27.24M | 2.07M |
Cash from Financing | -151.00M | -158.70M | -157.09M | -132.80M | -110.43M |
Foreign Exchange rate Adjustments | -2.72M | 535.00K | -960.00K | -346.00K | 470.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 163.00K | 7.97M | 1.02M | 7.36M | -4.65M |